These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25576256)

  • 1. Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles.
    Pereira de Sousa I; Steiner C; Schmutzler M; Wilcox MD; Veldhuis GJ; Pearson JP; Huck CW; Salvenmoser W; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):273-9. PubMed ID: 25576256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin loaded mucus permeating nanoparticles: Addressing the surface characteristics as feature to improve mucus permeation.
    Pereira de Sousa I; Moser T; Steiner C; Fichtl B; Bernkop-Schnürch A
    Int J Pharm; 2016 Mar; 500(1-2):236-44. PubMed ID: 26802494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier.
    Pereira de Sousa I; Cattoz B; Wilcox MD; Griffiths PC; Dalgliesh R; Rogers S; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):257-64. PubMed ID: 25661320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the synthesis of mucus permeating nanocarriers.
    Bourganis V; Karamanidou T; Samaridou E; Karidi K; Kammona O; Kiparissides C
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):239-49. PubMed ID: 25661586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle diffusion within intestinal mucus: Three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles.
    Abdulkarim M; Agulló N; Cattoz B; Griffiths P; Bernkop-Schnürch A; Borros SG; Gumbleton M
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):230-8. PubMed ID: 25661585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
    Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
    Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of phosphorylated nanoparticles as zeta potential inverting systems.
    Perera G; Zipser M; Bonengel S; Salvenmoser W; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):250-6. PubMed ID: 25638505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-emulsifying peptide drug delivery systems: How to make them highly mucus permeating.
    Griesser J; Hetényi G; Kadas H; Demarne F; Jannin V; Bernkop-Schnürch A
    Int J Pharm; 2018 Mar; 538(1-2):159-166. PubMed ID: 29339247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucus permeating thiomer nanoparticles.
    Köllner S; Dünnhaupt S; Waldner C; Hauptstein S; Pereira de Sousa I; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):265-72. PubMed ID: 25603199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
    Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
    ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zeta Potential Changing Polyphosphate Nanoparticles: A Promising Approach To Overcome the Mucus and Epithelial Barrier.
    Akkus ZB; Nazir I; Jalil A; Tribus M; Bernkop-Schnürch A
    Mol Pharm; 2019 Jun; 16(6):2817-2825. PubMed ID: 31070926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
    Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
    Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
    Giovino C; Ayensu I; Tetteh J; Boateng JS
    Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
    Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
    ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
    Lee JY; Chung SJ; Cho HJ; Kim DD
    Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
    Umerska A; Corrigan OI; Tajber L
    Int J Pharm; 2014 Dec; 477(1-2):102-12. PubMed ID: 25447822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation.
    Suchaoin W; Pereira de Sousa I; Netsomboon K; Lam HT; Laffleur F; Bernkop-Schnürch A
    Int J Pharm; 2016 Aug; 510(1):255-62. PubMed ID: 27329673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of microbicide nanoparticles with a simulated vaginal fluid.
    das Neves J; Rocha CM; Gonçalves MP; Carrier RL; Amiji M; Bahia MF; Sarmento B
    Mol Pharm; 2012 Nov; 9(11):3347-56. PubMed ID: 23003680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase.
    Sheng Y; He H; Zou H
    Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.